Table 3.
Doses to Organs at Risk (OAR) for Patients with Severe Late Toxicities (Cases) and Controls
| Cases (n = 71) |
Controls (n = 83) |
||||
|---|---|---|---|---|---|
| OAR | No. | % | No. | % | P-value |
| Superior Oropharynx, Gy Epiglottis | |||||
| Mean | 69.6 | 69.5 | 0.87 | ||
| Median | 70 | 70 | |||
| Min-Max | 50.6–72.0 | 55.0–72.3 | |||
| Inferior Oropharynx, Gy Superior Constrictor | |||||
| Mean | 63.8 | 63.3 | 0.77 | ||
| Median | 67.5 | 67.1 | |||
| Min-Max | 25.6–72.0 | 2.1–72.3 | |||
| Superior Hypopharynx, Gy Cricoarytenoid | |||||
| Mean | 63.3 | 57.0 | 0.015 | ||
| Median | 70 | 70 | |||
| Min-Max | 31.5–72.0 | 2.1–72.5 | |||
| Inferior Hypopharynx, Gy | |||||
| Mean | 49.7 | 41.4 | 0.025 | ||
| Median | 58.0 | 50.6 | |||
| Min-Max | 2.1–72.0 | 2.1–72.0 | |||